Literature DB >> 30087534

Modified Doppler-guided laser procedure for the treatment of second- and third-degree hemorrhoids.

Edward Ram1, Gil N Bachar2, Yuri Goldes1, Samia Joubran1, Lea Rath-Wolfson3.   

Abstract

BACKGROUND: Hemorrhoids are a common anorectal condition with a major medical and socioeconomic impact. Owing to the high incidence of symptomatic hemorrhoids in the adult population together with the risk of complications of traditional surgery, researchers are seeking less invasive methods of hemorrhoidal treatment.The aim of this study was to present our experience with the mini-invasive Doppler guided hemorrhoidal laser procedure (HeLP) in symptomatic 2nd and 3rd degree hemorrhoids with absent or minimal mucosal prolapse.
METHODS: The cohort included 62 patients with symptomatic hemorrhoids who underwent the HeLP at a tertiary medical center in 2014-2016. Data were collected on clinical and perioperative characteristics and outcome. Findings were compared between patients with second- and third-degree hemorrhoids.
RESULTS: The cohort included 41 male and 21 female patients of mean age 41.5 years. Fifty-one had bleeding and 11 had hemorrhoidal syndrome. Mean operative time was 16.6 ± 3.7 minutes. A total of 8-12 arterial branches were treated. Patients were discharged home within a mean of 91.95 ± 20.48 minutes and allowed to resume normal activities. Compared to patients with second-degree hemorrhoids, patients with third-degree hemorrhoids had a significantly higher rate of recto-anal repair (18.2% vs 0, p < 0.05), intraoperative bleeding (11.3% vs 5%, p < 0.05), and thrombus formation in the hemorrhoids (11.3 % vs 0, p < 0.01). At the six-month follow-up, no complications were reported, and there was significant improvement in symptoms.Using the visual analog scale, no pain was reported by 82.3% of patients at one week after surgery and 95.2% of patients at one month after surgery.
CONCLUSION: Patients with hemorrhoids treated with Doppler-guided laser had an excellent outcome in terms of resolution of symptoms and postoperative pain. Only Minor short-term complications were noted. Doppler-guided laser seems to be an effective and painless technique for the treatment of symptomatic second- to third grade hemorrhoids with minimal mucosal prolapse.

Entities:  

Keywords:  Doppler; Hemorrhoids; Laser procedure

Year:  2018        PMID: 30087534      PMCID: PMC6062676          DOI: 10.5978/islsm.18-OR-14

Source DB:  PubMed          Journal:  Laser Ther        ISSN: 0898-5901


  18 in total

1.  The prevalence of hemorrhoids in adults.

Authors:  Stefan Riss; Friedrich Anton Weiser; Katrin Schwameis; Thomas Riss; Martina Mittlböck; Gottfried Steiner; Anton Stift
Journal:  Int J Colorectal Dis       Date:  2011-09-20       Impact factor: 2.571

2.  Doppler-guided hemorrhoidal laser procedure for the treatment of symptomatic hemorrhoids: experimental background and short-term clinical results of a new mini-invasive treatment.

Authors:  Paolo Giamundo; Walter Cecchetti; Luigi Esercizio; Giovanni Fantino; Maria Geraci; Roberto Lombezzi; Michele Pittaluga; Livio Tibaldi; Giovanni Torre; Marco Valente
Journal:  Surg Endosc       Date:  2010-10-26       Impact factor: 4.584

3.  The hemorrhoid laser procedure technique vs rubber band ligation: a randomized trial comparing 2 mini-invasive treatments for second- and third-degree hemorrhoids.

Authors:  Paolo Giamundo; Raffaele Salfi; Maria Geraci; Livio Tibaldi; Luisa Murru; Marco Valente
Journal:  Dis Colon Rectum       Date:  2011-06       Impact factor: 4.585

4.  The vascular nature of hemorrhoids.

Authors:  Felix Aigner; Gerd Bodner; Hannes Gruber; Friedrich Conrad; Helga Fritsch; Raimund Margreiter; Hugo Bonatti
Journal:  J Gastrointest Surg       Date:  2006 Jul-Aug       Impact factor: 3.452

5.  Long-term outcome of rubber band ligation for symptomatic primary and recurrent internal hemorrhoids.

Authors:  V S Iyer; I Shrier; P H Gordon
Journal:  Dis Colon Rectum       Date:  2004-08       Impact factor: 4.585

Review 6.  Haemorrhoids: pathology, pathophysiology and aetiology.

Authors:  P B Loder; M A Kamm; R J Nicholls; R K Phillips
Journal:  Br J Surg       Date:  1994-07       Impact factor: 6.939

7.  Pain intensity on the first day after surgery: a prospective cohort study comparing 179 surgical procedures.

Authors:  Hans J Gerbershagen; Sanjay Aduckathil; Albert J M van Wijck; Linda M Peelen; Cor J Kalkman; Winfried Meissner
Journal:  Anesthesiology       Date:  2013-04       Impact factor: 7.892

8.  The superior rectal artery and its branching pattern with regard to its clinical influence on ligation techniques for internal hemorrhoids.

Authors:  Felix Aigner; Gerd Bodner; Friedrich Conrad; Godwin Mbaka; Alfons Kreczy; Helga Fritsch
Journal:  Am J Surg       Date:  2004-01       Impact factor: 2.565

9.  Advantages and limits of hemorrhoidal dearterialization in the treatment of symptomatic hemorrhoids.

Authors:  Paolo Giamundo
Journal:  World J Gastrointest Surg       Date:  2016-01-27

10.  Comparison of the information provided by electronic health records data and a population health survey to estimate prevalence of selected health conditions and multimorbidity.

Authors:  Concepción Violán; Quintí Foguet-Boreu; Eduardo Hermosilla-Pérez; Jose M Valderas; Bonaventura Bolíbar; Mireia Fàbregas-Escurriola; Pilar Brugulat-Guiteras; Miguel Ángel Muñoz-Pérez
Journal:  BMC Public Health       Date:  2013-03-21       Impact factor: 3.295

View more
  2 in total

1.  Hemorrhoid laser procedure with suture-pexy (HeLPexx): a novel effective procedure to treat hemorrhoidal disease.

Authors:  P Giamundo; M De Angelis; A Mereu
Journal:  Tech Coloproctol       Date:  2020-01-28       Impact factor: 3.781

Review 2.  Consensus statement of the Italian society of colorectal surgery (SICCR): management and treatment of hemorrhoidal disease.

Authors:  G Gallo; J Martellucci; A Sturiale; G Clerico; G Milito; F Marino; G Cocorullo; P Giordano; M Mistrangelo; M Trompetto
Journal:  Tech Coloproctol       Date:  2020-01-28       Impact factor: 3.781

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.